Related Experiment Video
Updated: May 30, 2026
A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
Published on: March 8, 2022
Unraveling the enigmatic complexities of BRMS1-mediated metastasis suppression
Douglas R Hurst1, Danny R Welch
1Department of Pathology, University of Alabama at Birmingham, Birmingham, AL 35294-0019, USA. DHurst@uab.edu
Abstract:
Expression of BRMS1 causes dramatic suppression of metastasis in multiple in vivo model systems. As we gain further insight into the biochemical mechanisms of BRMS1, we appreciate the importance of both molecular and cellular context for functional metastasis suppression. BRMS1 associates with large chromatin remodeling complexes including SIN3:HDAC which are powerful epigenetic regulators of gene expression. Additionally, BRMS1 inhibits the activity of NFκB, a well-known transcription factor that plays significant roles in tumor progression. Moreover, BRMS1 coordinately regulates the expression of metastasis-associated microRNA known as metastamir. How these biochemical mechanisms and biological pathways are linked, either directly or indirectly, and the influence of molecular and cellular context, are critical considerations for the discovery of novel therapeutic targets for the most deadly aspect of tumor progression-metastasis.
Insights
The BRMS1 protein suppresses cancer metastasis through epigenetic regulation and by inhibiting key tumor progression pathways. Understanding its mechanisms is crucial for developing new anti-metastasis therapies.
Area of Science:
- Oncology
- Molecular Biology
- Epigenetics
Background:
- Metastasis is a major cause of cancer mortality.
- BRMS1 is a known suppressor of metastasis in various models.
- The precise molecular mechanisms underlying BRMS1's function require further elucidation.
Purpose of the Study:
- To investigate the biochemical mechanisms by which BRMS1 suppresses metastasis.
- To understand the role of molecular and cellular context in BRMS1-mediated metastasis suppression.
- To identify potential therapeutic targets for inhibiting cancer metastasis.
Main Methods:
- In vivo metastasis models were utilized to assess BRMS1 function.
- Biochemical assays were performed to identify BRMS1 interacting partners.
- Analysis of gene expression, including microRNAs, was conducted.
Main Results:
- BRMS1 expression significantly suppressed metastasis in vivo.
- BRMS1 associates with chromatin remodeling complexes (e.g., SIN3:HDAC).
- BRMS1 inhibits NFκB activity and regulates metastamir expression.
Conclusions:
- BRMS1 employs multiple mechanisms, including epigenetic regulation and pathway inhibition, to suppress metastasis.
- Molecular and cellular context are critical for BRMS1's metastasis-suppressive function.
- BRMS1's pathways offer potential targets for novel anti-metastasis therapeutics.
Related Concept Videos
02:30Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
02:30Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
02:53Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
02:53Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...